Neogen Corp
NEOG6.530USD
+0.170+2.67%
Fechamento 11/11, 16:00（ET）Cotações atrasadas em 15 min
1.42BValor de mercado
PerdaP/L TTM
Mais detalhes de Neogen Corp Empresa
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
Informações de Neogen Corp
Código da empresaNEOG
Nome da EmpresaNeogen Corp
Data de listagemAug 23, 1989
CEOMr. Mikhael Nassif
Número de funcionários2974
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 23
Endereço620 Lesher Pl
CidadeLANSING
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal48912
Telefone15173729200
Sitehttps://www.neogen.com/
Código da empresaNEOG
Data de listagemAug 23, 1989
CEOMr. Mikhael Nassif
Executivos da empresa Neogen Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
116.12K
+28.34%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Operating Officer
Chief Operating Officer
81.02K
+16.11%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
57.24K
+29.59%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
45.53K
+107.76%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
36.86K
+178.32%
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
36.40K
+184.78%
Ms. Andrea F. Wainer
Ms. Andrea F. Wainer
Independent Director
Independent Director
25.86K
+324.61%
Mr. Thierry Bernard
Mr. Thierry Bernard
Independent Director
Independent Director
25.39K
+351.76%
Mr. Avi Pelossof
Mr. Avi Pelossof
Director
Director
19.39K
--
Mr. Bryan Riggsbee
Mr. Bryan Riggsbee
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
116.12K
+28.34%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Operating Officer
Chief Operating Officer
81.02K
+16.11%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
57.24K
+29.59%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
45.53K
+107.76%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
36.86K
+178.32%
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
36.40K
+184.78%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Culture Media & Other
325.92M
36.43%
Bacterial & General Sanitation
164.78M
18.42%
Rodenticides, Insecticides & Disinfectants
135.03M
15.09%
Genomics Services
89.25M
9.98%
Natural Toxins, Allergens & Drug Residues
77.06M
8.61%
Outro
102.62M
11.47%
Por RegiãoUSD
Nome
Receita
Proporção
International
448.73M
50.16%
Domestic
445.94M
49.84%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Culture Media & Other
325.92M
36.43%
Bacterial & General Sanitation
164.78M
18.42%
Rodenticides, Insecticides & Disinfectants
135.03M
15.09%
Genomics Services
89.25M
9.98%
Natural Toxins, Allergens & Drug Residues
77.06M
8.61%
Outro
102.62M
11.47%
Distribuição de ações
Atualizado em: há 8 horas
Atualizado em: há 8 horas
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
12.68%
The Vanguard Group, Inc.
11.01%
ING Bank N.V.
6.47%
Clarkston Capital Partners, LLC
6.45%
Gates Capital Management, Inc.
5.89%
Outro
57.51%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
12.68%
The Vanguard Group, Inc.
11.01%
ING Bank N.V.
6.47%
Clarkston Capital Partners, LLC
6.45%
Gates Capital Management, Inc.
5.89%
Outro
57.51%
Tipos de investidores
Investidores
Proporção
Investment Advisor
46.88%
Investment Advisor/Hedge Fund
36.51%
Hedge Fund
15.72%
Bank and Trust
6.93%
Research Firm
5.01%
Sovereign Wealth Fund
4.25%
Pension Fund
1.57%
Individual Investor
0.89%
Private Equity
0.29%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
733
254.38M
117.06%
-53.44M
2025Q2
720
240.23M
110.60%
-42.75M
2025Q1
753
280.62M
129.30%
-9.42M
2024Q4
764
265.86M
122.55%
-15.84M
2024Q3
778
258.29M
119.19%
-21.39M
2024Q2
791
255.45M
117.89%
-8.15M
2024Q1
783
241.86M
111.66%
-5.94M
2023Q4
783
234.38M
108.27%
-1.28M
2023Q3
770
225.33M
104.20%
-18.20M
2023Q2
761
232.20M
107.41%
-2.78M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
27.55M
12.68%
-1.06M
-3.71%
Jun 30, 2025
The Vanguard Group, Inc.
23.53M
10.83%
+27.21K
+0.12%
Jun 30, 2025
Clarkston Capital Partners, LLC
14.01M
6.45%
+7.73M
+123.16%
Jun 30, 2025
Gates Capital Management, Inc.
12.79M
5.89%
+3.64M
+39.72%
Jun 30, 2025
Southpoint Capital Advisors LP
10.00M
4.6%
+10.00M
--
Jun 30, 2025
William Blair Investment Management, LLC
9.40M
4.33%
-4.16M
-30.65%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
9.13M
4.2%
+697.10K
+8.26%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
9.08M
4.18%
-5.73M
-38.70%
Jun 30, 2025
State Street Investment Management (US)
8.59M
3.95%
-18.09K
-0.21%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
SPDR S&P Health Care Equipment ETF
1.68%
Invesco S&P SmallCap Health Care ETF
0.79%
Invesco NASDAQ Future Gen 200 ETF
0.48%
Federated Hermes MDT Small Cap Core ETF
0.3%
VanEck Agribusiness ETF
0.29%
Inspire Small/Mid Cap ESG ETF
0.23%
Amplify Etho Climate Leadership U.S. ETF
0.19%
Invesco S&P SmallCap 600 Pure Value ETF
0.18%
SPDR S&P 600 Small Cap Value ETF
0.17%
iShares S&P Small-Cap 600 Value ETF
0.17%
Ver Mais
SPDR S&P Health Care Equipment ETF
Proporção1.68%
Invesco S&P SmallCap Health Care ETF
Proporção0.79%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.48%
Federated Hermes MDT Small Cap Core ETF
Proporção0.3%
VanEck Agribusiness ETF
Proporção0.29%
Inspire Small/Mid Cap ESG ETF
Proporção0.23%
Amplify Etho Climate Leadership U.S. ETF
Proporção0.19%
Invesco S&P SmallCap 600 Pure Value ETF
Proporção0.18%
SPDR S&P 600 Small Cap Value ETF
Proporção0.17%
iShares S&P Small-Cap 600 Value ETF
Proporção0.17%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
May 12, 2021
Split
1→2
Data
Tipo
Proporção
May 12, 2021
Split
1→2
